XML 28 R21.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

May 03, 2025

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis

The following table presents financial instruments that are measured at fair value on a recurring basis at May 3, 2025, February 1, 2025 and May 4, 2024:


		Fair Value Measurements
(In thousands)		Level 1				Level 2				Level 3				Total
As of May 3, 2025
Cash equivalents - money market mutual funds		$	68,330			$	0			$	0			$	68,330
Marketable securities - mutual funds that fund deferred compensation			14,477				0				0				14,477
Total		$	82,807			$	0			$	0			$	82,807
As of February 1, 2025
Cash equivalents - money market mutual funds		$	95,963			$	0			$	0			$	95,963
Marketable securities - mutual funds that fund deferred compensation			14,432												14,432
Total		$	110,395			$	0			$	0			$	110,395
As of May 4, 2024
Cash equivalents - money market mutual funds		$	40,588			$	0			$	0			$	40,588
Marketable securities - mutual funds that fund deferred compensation			12,555												12,555
Total		$	53,143			$	0			$	0			$	53,143

Schedule Of Deferred Compensation Plan Liabilities And Related Marketable Securities

The following tables present the balances and activity of the Company’s deferred compensation plan liabilities and related Marketable Securities:


(In thousands)		May 3, 2025				February 1, 2025				May 4, 2024
Deferred compensation plan current liabilities		$	4,266			$	4,259			$	183
Deferred compensation plan long-term liabilities			9,539				10,011				12,157
Total deferred compensation plan liabilities		$	13,805			$	14,270			$	12,340
Marketable securities - mutual funds that fund deferred compensation		$	14,477			$	14,432			$	12,555


(In thousands)		Thirteen Weeks Ended May 3, 2025				Thirteen Weeks Ended May 4, 2024
Deferred compensation liabilities
Employer contributions, net		$	114			$	81
Investment (losses) earnings			(436	)			323
Marketable Securities
Mark-to-market losses (gains) (1)			605				(308	)
Net deferred compensation expense		$	283			$	96

(1) Included in the mark-to-market activity related to equity securities still held at quarter-end, we recognized an unrealized loss of $94,000 and an unrealized gain of $292,000 for the thirteen weeks ended May 3, 2025 and May 4, 2024, respectively.